In solid tumors, including prostate cancer and breast cancer, STAT3 activation which was mediated by IL-6 could enhance the expression of anti-apoptotic proteins, such as BCL2 or survivin which has constantly been regarded as a protective mechanism from chemotherapy-induced cell death (37–39). The gene discussed is BCL2; the disease is prostate cancer.